Literature DB >> 24700654

Effect of age on regulation of human osteoclast differentiation.

Ping-Lin Chung1, Shuanhu Zhou, Behnam Eslami, Longxiang Shen, Meryl S LeBoff, Julie Glowacki.   

Abstract

Human skeletal aging is characterized as a gradual loss of bone mass due to an excess of bone resorption not balanced by new bone formation. Using human marrow cells, we tested the hypothesis that there is an age-dependent increase in osteoclastogenesis due to intrinsic changes in regulatory factors [macrophage-colony stimulating factor (M-CSF), receptor activator of NF-κB ligand (RANKL), and osteoprotegerin (OPG)] and their receptors [c-fms and RANK]. In bone marrow cells (BMCs), c-fms (r = 0.61, P = 0.006) and RANK expression (r = 0.59, P = 0.008) were increased with age (27-82 years, n = 19). In vitro generation of osteoclasts was increased with age (r = 0.89, P = 0.007). In enriched marrow stromal cells (MSCs), constitutive expression of RANKL was increased with age (r = 0.41, P = 0.049) and expression of OPG was inversely correlated with age (r = -0.43, P = 0.039). Accordingly, there was an age-related increase in RANKL/OPG (r = 0.56, P = 0.005). These data indicate an age-related increase in human osteoclastogenesis that is associated with an intrinsic increase in expression of c-fms and RANK in osteoclast progenitors, and, in the supporting MSCs, an increase in pro-osteoclastogenic RANKL expression and a decrease in anti-osteoclastogenic OPG. These findings support the hypothesis that human marrow cells and their products can contribute to skeletal aging by increasing the generation of bone-resorbing osteoclasts. These findings help to explain underlying molecular mechanisms of progressive bone loss with advancing age in humans.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  AGING; MARROW STROMAL CELL; OPG; OSTEOCLAST; RANKL

Mesh:

Substances:

Year:  2014        PMID: 24700654      PMCID: PMC4096781          DOI: 10.1002/jcb.24792

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  44 in total

1.  Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice.

Authors:  Mohammad Shahnazari; Denise Dwyer; Vivian Chu; Frank Asuncion; Marina Stolina; Michael Ominsky; Paul Kostenuik; Bernard Halloran
Journal:  Bone       Date:  2011-11-30       Impact factor: 4.398

2.  1,25(OH)2D3 induces differentiation of osteoclast-like cells from human bone marrow cultures.

Authors:  M Thavarajah; D B Evans; J A Kanis
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

3.  Age-related decline in osteoblastogenesis and 1α-hydroxylase/CYP27B1 in human mesenchymal stem cells: stimulation by parathyroid hormone.

Authors:  Shuo Geng; Shuanhu Zhou; Julie Glowacki
Journal:  Aging Cell       Date:  2011-08-24       Impact factor: 9.304

4.  Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Authors:  N Udagawa; N Takahashi; E Jimi; K Matsuzaki; T Tsurukai; K Itoh; N Nakagawa; H Yasuda; M Goto; E Tsuda; K Higashio; M T Gillespie; T J Martin; T Suda
Journal:  Bone       Date:  1999-11       Impact factor: 4.398

5.  In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status.

Authors:  D Cheleuitte; S Mizuno; J Glowacki
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

6.  Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures.

Authors:  B R MacDonald; N Takahashi; L M McManus; J Holahan; G R Mundy; G D Roodman
Journal:  Endocrinology       Date:  1987-06       Impact factor: 4.736

7.  Osteopetrosis cured by temporary parabiosis.

Authors:  D G Walker
Journal:  Science       Date:  1973-05-25       Impact factor: 47.728

8.  Modifying RANKL/OPG mRNA expression in differentiating and growing human primary osteoblasts.

Authors:  M Giner; M J Montoya; M A Vázquez; M J Rios; R Moruno; M J Miranda; R Pérez-Cano
Journal:  Horm Metab Res       Date:  2008-10-17       Impact factor: 2.936

9.  Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.

Authors:  Jay Cao; Laura Venton; Takeshi Sakata; Bernard P Halloran
Journal:  J Bone Miner Res       Date:  2003-02       Impact factor: 6.741

10.  Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement.

Authors:  Matthew D Dunn; Chan Ho Park; Paul J Kostenuik; Sunil Kapila; William V Giannobile
Journal:  Bone       Date:  2007-05-08       Impact factor: 4.398

View more
  27 in total

Review 1.  Similarities Between Disuse and Age-Induced Bone Loss.

Authors:  Evan G Buettmann; Galen M Goldscheitter; Gabriel A Hoppock; Michael A Friedman; Larry J Suva; Henry J Donahue
Journal:  J Bone Miner Res       Date:  2022-07-28       Impact factor: 6.390

2.  Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis.

Authors:  Sung Hye Kong; Jung Hee Kim; Sang Wan Kim; Ae Jin Jeong; Song-Hee Lee; Sang-Kyu Ye; Chan Soo Shin
Journal:  J Bone Metab       Date:  2022-05-31

Review 3.  Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells.

Authors:  Shuo Geng; Shuanhu Zhou; Zhenggang Bi; Julie Glowacki
Journal:  Metabolism       Date:  2013-01-30       Impact factor: 8.694

4.  Aging and menopause reprogram osteoclast precursors for aggressive bone resorption.

Authors:  Anaïs Marie Julie Møller; Jean-Marie Delaissé; Jacob Bastholm Olesen; Jonna Skov Madsen; Luisa Matos Canto; Troels Bechmann; Silvia Regina Rogatto; Kent Søe
Journal:  Bone Res       Date:  2020-07-01       Impact factor: 13.567

5.  Interplay between low plasma RANKL and VDR-FokI polymorphism in lumbar disc herniation independently from age, body mass, and environmental factors: a case-control study in the Italian population.

Authors:  Veronica Sansoni; Silvia Perego; Alessandra Colombini; Giuseppe Banfi; Marco Brayda-Bruno; Giovanni Lombardi
Journal:  Eur Spine J       Date:  2015-08-11       Impact factor: 3.134

6.  Euodia sutchuenensis Dode extract stimulates osteoblast differentiation via Wnt/β-catenin pathway activation.

Authors:  Jeong-Ha Hwang; Pu-Hyeon Cha; Gyoonhee Han; Tran The Bach; Do Sik Min; Kang-Yell Choi
Journal:  Exp Mol Med       Date:  2015-03-20       Impact factor: 8.718

7.  Paracrine effects of haematopoietic cells on human mesenchymal stem cells.

Authors:  Shuanhu Zhou
Journal:  Sci Rep       Date:  2015-06-01       Impact factor: 4.379

8.  Age-dependent modulation of bone metabolism in zebrafish scales as new model of male osteoporosis in lower vertebrates.

Authors:  Marta Carnovali; Giuseppe Banfi; Massimo Mariotti
Journal:  Geroscience       Date:  2020-09-30       Impact factor: 7.713

9.  Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.

Authors:  Zhaofei Li; Yanfang Zhao; Zhu Chen; Jannet Katz; Suzanne M Michalek; Yuhong Li; Ping Zhang
Journal:  Mol Immunol       Date:  2021-07-16       Impact factor: 4.174

Review 10.  Senescence and aging: Causes, consequences, and therapeutic avenues.

Authors:  Domhnall McHugh; Jesús Gil
Journal:  J Cell Biol       Date:  2017-11-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.